OptCare Plus
Curative Health Services, Inc. (Nasdaq: CURE) has completed the acquisition of OptCare Plus, Inc., a specialty pharmacy with a primary focus on dispensing biological medications such as Hemophilia clotting factors.
Curative Health Services, Inc. (Nasdaq: CURE) has completed the acquisition of OptCare Plus, Inc., a specialty pharmacy with a primary focus on dispensing biological medications such as Hemophilia clotting factors.